Item 8.01 Other Events.
On January 22, 2020, the Board of Directors of Outlook Therapeutics, Inc. (the
"Company") established that the Company's 2020 Annual Meeting of Stockholders
(the "2020 Annual Meeting") will be held on Thursday, March 19, 2020. The record
date for the determination of stockholders of the Company entitled to receive
notice of and to vote at the 2020 Annual Meeting shall be the close of business
on Friday, February 7, 2020. Because the date of the 2020 Annual Meeting differs
by more than thirty (30) days from the anniversary date of the 2019 Annual
Meeting of Stockholders (the "2019 Annual Meeting"), which was held on September
12, 2019, the deadlines for any stockholder proposals pursuant to Rule 14a-8
under the Securities Exchange Act of 1934, as amended (the "Exchange Act") and
for any stockholder nomination or proposal outside of Rule 14a-8, as listed in
the Company's 2019 Proxy Statement on Schedule 14A, as filed with the Securities
and Exchange Commission (the "SEC") on August 1, 2019, are no longer applicable.
Pursuant to the Company's bylaws (the "Bylaws") and Rule 14a-5(f) of the
Exchange Act, the Company is hereby providing notice of the revised deadlines
for such proposals via this Form 8-K.
To be considered for inclusion in this year's proxy materials for the 2020
Annual Meeting, stockholder proposals must be submitted in writing by February
2, 2020, to the Company's Corporate Secretary at 7 Clarke Drive, Cranbury, New
Jersey 08512. In addition to complying with this deadline, stockholder proposals
intended to be considered for inclusion in the Company's proxy materials for the
2020 Annual Meeting must also comply with the Bylaws and all applicable rules
and regulations promulgated by the SEC under the Exchange Act. Additionally, any
stockholder who intends to submit a proposal regarding a director nomination or
who intends to submit a proposal regarding any other matter of business at the
2020 Annual Meeting not to be included in the Company's proxy materials for the
2020 Annual Meeting, must also ensure that notice of any such nomination or
proposal (including any additional information specified in the Bylaws) is
received by the Corporate Secretary at the Company's principal executive offices
on or before the close of business on February 2, 2020.
© Edgar Online, source Glimpses
OUTLOOK THERAPEUTICS, INC. 
